Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer

Breast Cancer Research and Treatment

Volumn 96, Issue 1, 2006, Pages 73-81

  Gellert, Ginelle C ^a   Dikmen, Z Gunnur ^a   Wright, Woodring E ^a   Gryaznov, Sergei ^b   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b GERON CORPORATION   (United States)

Author keywords

Breast cancer; Oligonucleotide; Telomerase inhibitor; Therapeutics

Indexed keywords

AGAR; GRN 163 L; OLIGONUCLEOTIDE; TELOMERASE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CELL PROLIFERATION; CLONAL VARIATION; CLONE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TELOMERE;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; COLONY-FORMING UNITS ASSAY; DRUG COMBINATIONS; FEMALE; HUMANS; LAMININ; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES; OLIGOPEPTIDES; PROTEOGLYCANS; TELOMERASE; TELOMERE;

EID: 33645244083     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9043-5     Document Type: Article

References (24)

1. Blackburn EH: Switching, signaling at the telomere. Cell 106: 661-673, 2001
2. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282, 1991
3. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990
4. Greider CW, Blackburn EH: Telomeres, telomerase and cancer. Sci Am 274: 92-97, 1996
5. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1996
6. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 396-352, 1998
7. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ: Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88, 1998
8. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, Herron GS: Human endothelial cell life extension by telomerase expression. J Biol Chem 274: 26141-26148, 1999
9. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997
10. Mokbel K: The role of telomerase in breast cancer. Eur J Surg Oncol 26: 509-514, 2000
11. Shay JW, Wright WE: Telomeres and telomerase: implications for cancer and aging. Radiat Res 155: 188-193, 2001
12. Shay JW, Zou Y, Hiyama E, Wright WE: Telomerase and cancer. Hum Mol Genet 10: 677-685, 2001
13. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
14. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996
15. Allred DC, O'Connell P, Fuqua SA: Biomarkers in early breast neoplasia. J Cell Biochem Suppl 17G: 125-131, 1993
16. Poremba C, Shroyer KR, Frost M, Diallo R, Fogt F, Schafer KL, Burger H, Shroyer AL, Dockhorn-Dworniczak B, Boecker W: Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions. J Clin Oncol 17: 2020-2026, 1999
17. Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R, Vidaud M: Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6: 452-459, 2000
18. Hoos A, Hepp HH, Kaul S, Ahlert T, Bastert G, Wallwiener D: Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 79: 8-12, 1998
19. White LK, Wright WE, Shay JW: Telomerase inhibitors. Trends Biotechnol 19: 114-120, 2001
20. Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, Shay JW, Corey DR: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 96: 14276-14281, 1999
21. Herbert BS, Pongracz K, Shay JW, Gryaznov SM, Shea-Herbert B: Oligonucleotide N3′-> P5′ phosphoramidates as efficient telomerase inhibitors. Oncogene 21: 638-642, 2002
22. Asai A, Oshima Y, Yamamoto Y, Uochi TA, Kusaka H, Akinaga S, Yamashita Y, Pongracz K, Pruzan R, Wunder E, Piatyszek M, Li S, Chin AC, Harley CB, Gryaznov S: A novel telomerase template antagonist (GRN163) as a potential anticancer agent. Cancer Res 63: 3931-3939, 2003
23. Gryaznov S, Pongracz K, Matray T, Schultz R, Pruzan R, Aimi J, Chin A, Harley C, Shea-Herbert B, Shay J, Oshima Y, Asai A, Yamashita Y: Telomerase inhibitors-oligonucleotide phosphoramidates as potential therapeutic agents. Nucleos Nucleot Nucleic Acids 20: 401-410, 2001
24. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO: Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13: 2388-2399, 1999